These effects increased in the expression of downstream tumor suppressor genes, including E-cadherin (CDH1), slit guidance ligand 2 (SLIT2), and TIMP3, and thereby reducing prostate cancer cell proliferation and invasion [112]. The gene discussed is CDH1; the disease is prostate carcinoma.